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AVMA Sponsors Meeting on FDA's
Revised Drug-Use Policy
A recently announced change in the Food
and Drug Administration (FDA) policy on the
use of drugs in food-producing animals re-
sulted in a conference called by the AVMA at
its Schaumburg, Illinois, headquarters on Sep-
tember 27, 1983.
The meeting was organized in response to an
outcry of concern from veterinarians and pro-
ducers that a new policy announced by the
FD.Ns Bureau of Veterinary Medicine last July
would impose excessive restrictions on extra-
label use of food-animal drugs. Under the
FD.Ns revised policy, a finding of illegal drug
residues will no longer be the only reason for
initiating punitive action. The revised policy
states that use of a drug in food animals for a
purpose or in a dosage not specified on the
product's label directions will also be justifica-
tion for punitive action.
The changes recommended at the September
conference would assure that the FDA will not
interfere when, in the veterinarian's profes-
sional judgment, there is a need to treat a food
animal with a drug or a dosage not specifically
approved by the FDA for an existing disease
condition.
124
It is expected that the recommended changes
will be reviewed for possible endorsement by
the AVMA and other national groups, and
, hopefully acted upon by FDA authorities.
If the FDA fails to amend its revised policy, it
is possible that veterinarians will be practicing
under a regulatory cloud of impropriety when
they decide to use a drug for purposes not ex-
actly stated on the label.
However, if the recommended changes are
adopted, FDA authorities would continue to
take action against veterinarians in cases where
drugs are illegally used and/or distributed for
purposes not stated on the product label, and
in the absence of a veterinarian-client-patient
relationship. FDA authorities would respect
the veterinarian's professional prerogatives
when a veterinarian-client-patient relationship
has been established so that the veterinarian is
familiar with the owner, the animal, the prem-
ises, and knows the management conditions.
FDA authorities, however, will still hold the
veterinarian and the client responsible for any
drug residues in food products that may occur
following treatment regimens that do not fol-
low label directions.
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